Difference between revisions of "Exaggerated placental site"

Jump to navigation Jump to search
Line 33: Line 33:
*MIB1 ~0%.
*MIB1 ~0%.
**Used to differentiate from [[PSTT]].
**Used to differentiate from [[PSTT]].
*hPL +ve.<ref name=pmid7014653>{{cite journal |author=Heyderman E, Gibbons AR, Rosen SW |title=Immunoperoxidase localisation of human placental lactogen: a marker for the placental origin of the giant cells in 'syncytial endometritis' of pregnancy |journal=J. Clin. Pathol. |volume=34 |issue=3 |pages=303–7 |year=1981 |month=March |pmid=7014653 |pmc=1146481 |doi= |url=}}</ref>
*hPL +ve.<ref name=pmid7014653>{{cite journal |author=Heyderman E, Gibbons AR, Rosen SW |title=Immunoperoxidase localisation of human placental lactogen: a marker for the placental origin of the giant cells in 'syncytial endometritis' of pregnancy |journal=J. Clin. Pathol. |volume=34 |issue=3 |pages=303–7 |year=1981 |month=March |pmid=7014653 |pmc=1146481 |doi= |url=}}</ref><ref name=pmid15498215/>
*CK18 +ve.<ref name=pmid15498215>{{cite journal |author=Shen DH, Liao XY, Liu YL, Wang H, Yu YZ |title=[Clinicopathological study of intermediate trophoblastic non-tumor lesions: exaggerated placental site and placental site nodule] |language=Chinese |journal=Zhonghua Bing Li Xue Za Zhi |volume=33 |issue=5 |pages=441–4 |year=2004 |month=October |pmid=15498215 |doi= |url=}}</ref>


==See also==
==See also==
48,830

edits

Navigation menu